Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Soligenix stock | $1.06

Learn how to easily invest in Soligenix stock.

Soligenix Inc is a biotechnology business based in the US. Soligenix shares (SNGX) are listed on the NASDAQ and all prices are listed in US Dollars. Soligenix employs 17 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Soligenix

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SNGX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Soligenix stock price (NASDAQ: SNGX)

Use our graph to track the performance of SNGX stocks over time.

Soligenix shares at a glance

Information last updated 2021-10-18.
Latest market close$1.06
52-week range$0.85 - $2.78
50-day moving average $1.06
200-day moving average $1.11
Wall St. target price$4.88
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.34

Buy Soligenix shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Soligenix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Soligenix price performance over time

Historical closes compared with the close of $1.06 from 2021-10-18

1 week (2021-10-13) 0.95%
1 month (2021-09-20) 3.92%
3 months (2021-07-20) 13.98%
6 months (2021-04-20) -17.19%
1 year (2020-10-20) -37.65%
2 years (2019-10-18) 20.39%
3 years (2018-10-19) 1.27
5 years (2016-10-20) 5.08

Soligenix financials

Revenue TTM $1.3 million
Gross profit TTM $538,498
Return on assets TTM -37.44%
Return on equity TTM -107.18%
Profit margin 0%
Book value $0.39
Market capitalisation $44.1 million

TTM: trailing 12 months

Shorting Soligenix shares

There are currently 1.0 million Soligenix shares held short by investors – that's known as Soligenix's "short interest". This figure is 31% down from 1.5 million last month.

There are a few different ways that this level of interest in shorting Soligenix shares can be evaluated.

Soligenix's "short interest ratio" (SIR)

Soligenix's "short interest ratio" (SIR) is the quantity of Soligenix shares currently shorted divided by the average quantity of Soligenix shares traded daily (recently around 4.0 million). Soligenix's SIR currently stands at 0.26. In other words for every 100,000 Soligenix shares traded daily on the market, roughly 260 shares are currently held short.

However Soligenix's short interest can also be evaluated against the total number of Soligenix shares, or, against the total number of tradable Soligenix shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Soligenix's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Soligenix shares in existence, roughly 30 shares are currently held short) or 0.0259% of the tradable shares (for every 100,000 tradable Soligenix shares, roughly 26 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Soligenix.

Find out more about how you can short Soligenix stock.

Soligenix share dividends

We're not expecting Soligenix to pay a dividend over the next 12 months.

Have Soligenix's shares ever split?

Soligenix's shares were split on a 1:10 basis on 6 October 2016. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Soligenix shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Soligenix shares which in turn could have impacted Soligenix's share price.

Soligenix share price volatility

Over the last 12 months, Soligenix's shares have ranged in value from as little as $0.85 up to $2.78. A popular way to gauge a stock's volatility is its "beta".

SNGX.US volatility(beta: 1.3)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Soligenix's is 1.3016. This would suggest that Soligenix's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Soligenix overview

Soligenix, Inc. , a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301, a novel photodynamic therapy, which has completed Phase III clinical trial to treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase III clinical trial to treat oral mucositis in head and neck cancer. This segment also offers proprietary formulations of oral beclomethasone 17,21-dipropionate, which has completed Phase I/II clinical trial for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation, including SGX203 for pediatric Crohn's disease and SGX201 for acute radiation enteritis. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia and Ib clinical trials; SGX943, a melioidosis therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate in pre-clinical development for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc.

Frequently asked questions

What percentage of Soligenix is owned by insiders or institutions?
Currently 0.151% of Soligenix shares are held by insiders and 6.858% by institutions.
How many people work for Soligenix?
Latest data suggests 17 work at Soligenix.
When does the fiscal year end for Soligenix?
Soligenix's fiscal year ends in December.
Where is Soligenix based?
Soligenix's address is: 29 Emmons Drive, Princeton, NJ, United States, 08540
What is Soligenix's ISIN number?
Soligenix's international securities identification number is: US8342233074
What is Soligenix's CUSIP number?
Soligenix's Committee on Uniform Securities Identification Procedures number is: 258094101

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site